MONTREAL, MAY 14, 2013 — /PRNewswire/ -- Halo Pharma today announced that it has taken a minority ownership position in, and established a formal collaboration with, the drug formulation and ...

Embrace Technology Innovations to Optimise LNP Formulation, Alternative LNP Raw Materials, Process Control to Achieve Seamless Scale-Up, Compliance & Cost Effectiveness ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. DSI, a PLG Company. (2024, July 11). Materialization Characterization and Formulation Development.

Major players in the formulation development outsourcing market are Syngene International Ltd., Aizant Drug Research Solutions Private Limited., Catalent Inc., Intertek Group plc, Recipharm AB ...

Addressing protein aggregation, product stability, supply chains, and regulations requires multiple tools, including ...

SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...

He has more than 16 years of experience in Pharma/CDMO, discovering and developing small molecule, peptide, oligonucleotide/siRNA, biologics, mRNA and LNP drug products. His expertise is in ...

MARTINSRIED-MUNICH, Germany, December 06, 2022 / B3C newswire / --Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of ...

However, it is also a systematic method of process development which delivers consistency, robustness and increased process knowledge. This course introduces QbD across all areas of pharmaceutical ...